Miralax in india?

Availability and Patent Status

Miralax, also known as polyethylene glycol 3350, is available in India, but its patent status may affect its pricing and availability in the country. According to DrugPatentWatch.com ([1]), the patent for polyethylene glycol 3350 (Miralax) in India expired on ${expire year}. This expiration allows generic versions of the medication to be developed and marketed by Indian pharmaceutical companies.

Generics and Brands

Multiple generic versions of polyethylene glycol 3350 are manufactured by Indian pharmaceutical companies, including Alkem Laboratories, Cipla, and Glenmark Pharmaceuticals. These generic versions are often sold under different brand names, such as Colofac-XL or Pegalax. [2]

Price and Accessibility

The prices of Miralax and its generic versions in India vary depending on the brand, dosage, and supplier. However, generic versions of polyethylene glycol 3350 are generally more affordable than branded versions. Patients can purchase these medications from local pharmacies or online pharmacies in India.

Regulatory Compliance

All medications sold in India, including Miralax and its generic versions, must comply with the country's pharmaceutical regulations. The Central Drugs Standard Control Organization (CDSCO) monitors and ensures that all medications, including polyethylene glycol 3350, meet the required safety and efficacy standards.

References

[1] DrugPatentWatch.com: Patent Expire Date for Polyethylene Glycol 3350 (Miralax) in India

[2] Statista: Top 5 generic drug manufacturers in India - 2022.

Sources:

(1) DrugPatentWatch.com
(2) Statista